No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Neutralizing
-
Antibodies, Viral
-
COVID-19 Vaccines
-
COVID-19* / prevention & control
-
Humans
-
Neutralization Tests
-
SARS-CoV-2 / genetics
-
Spike Glycoprotein, Coronavirus / genetics
-
Vaccines, Inactivated
Substances
-
Antibodies, Neutralizing
-
Antibodies, Viral
-
COVID-19 Vaccines
-
SARS-CoV-2 inactivated vaccines
-
Spike Glycoprotein, Coronavirus
-
Vaccines, Inactivated
-
spike protein, SARS-CoV-2
Grants and funding
This study was supported by the National Science Fund for Distinguished Young Scholars (82025022), the National Natural Science Foundation of China (82002140, 82171752, 82101861), the Guangdong Basic and Applied Basic Research Foundation (2021B1515020034, 2019A1515011197, 2021A1515011009, 2020A1515110656), and the Shenzhen Science and Technology Program (RCYX20200714114700046, JSGG20200207155251653, JCYJ20210324131606018, JSGG20200807171401008, KQTD20200909113758004, JCYJ20190809115617365).